Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months. EB613 single ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果